載入...
Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 1—Biosimilar and Originator Infliximab in the Hospital Setting
BACKGROUND: Decentralisation of healthcare budgets and issuance of local guidelines means that the use of biosimilars can vary by region within a particular country, for example between the 21 counties of Sweden. OBJECTIVES: This study aimed to analyse the county-level market dynamics of biosimilar...
Na minha lista:
| 發表在: | BioDrugs |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer International Publishing
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6533410/ https://ncbi.nlm.nih.gov/pubmed/30945207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-019-00345-6 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|